| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 13 | 0.386 | 0.846 | 1.4E-02 |
|
phenotype | 0.400 | None | 1.000 | 3 | 3 | 2011 | 2017 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
phenotype | 0.400 | None | 1.000 | 1 | 1 | 1996 | 2018 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.400 | None | 1.000 | 1 | 1 | 2011 | 2017 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
phenotype | 0.400 | None | 1.000 | 1 | 1 | 2013 | 2017 | ||||||||
|
SMAD family member 3 | 0.415 | 0.923 | 0.80 |
|
phenotype | 0.100 | None | 1.000 | 4 | 4 | 2013 | 2018 | ||||||||
|
toll like receptor 1 | 0.496 | 0.808 | 5.9E-23 |
|
phenotype | 0.100 | None | 1.000 | 4 | 4 | 2013 | 2018 | ||||||||
|
gasdermin B | 0.670 | 0.500 | 3.3E-07 |
|
phenotype | 0.100 | None | 1.000 | 4 | 4 | 2013 | 2018 | ||||||||
|
long intergenic non-protein coding RNA 299 | 0.743 | 0.346 |
|
phenotype | 0.100 | None | 1.000 | 4 | 2 | 2013 | 2018 | |||||||||
|
arginine-glutamic acid dipeptide repeats | 0.526 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2018 | ||||||||
|
signal transducer and activator of transcription 6 | 0.475 | 0.808 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2016 | 2018 | ||||||||
|
D-2-hydroxyglutarate dehydrogenase | 0.691 | 0.500 | 5.4E-02 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2016 | 2018 | ||||||||
|
interleukin 1 receptor like 1 | 0.547 | 0.731 | 1.4E-12 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2013 | 2018 | ||||||||
|
tetratricopeptide repeat domain 6 | 0.931 | 0.154 | 1.1E-25 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2013 | 2017 | ||||||||
|
T helper type 2 locus control region associated RNA | 0.751 | 0.385 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2013 | 2017 | |||||||||
|
LIM domain containing preferred translocation partner in lipoma | 0.543 | 0.769 | 7.2E-03 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2013 | 2017 | ||||||||
|
phospholipase C like 1 (inactive) | 0.608 | 0.654 | 1.2E-02 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2013 | 2017 | ||||||||
|
interleukin 18 receptor 1 | 0.473 | 0.808 | 8.6E-06 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2013 | 2018 | ||||||||
|
RAD51 paralog B | 0.556 | 0.769 | 2.1E-15 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2017 | 2018 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | |||||||||
|
FLG antisense RNA 1 | 0.700 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2017 | 2018 | |||||||||
|
interleukin 7 receptor | 0.487 | 0.769 | 3.8E-07 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2018 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2018 | ||||||||
|
negative regulator of reactive oxygen species | 0.861 | 0.231 | 0.33 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2018 | ||||||||
|
C-type lectin domain containing 16A | 0.612 | 0.654 | 0.28 |
|
phenotype | 0.100 | None | 1.000 | 2 | 4 | 2013 | 2018 | ||||||||
|
RTEL1-TNFRSF6B readthrough (NMD candidate) | 0.682 | 0.385 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2018 |